Cargando…
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
BACKGROUND: After receiving a COVID-19 vaccine, most recipients want to know if they are protected from infection and for how long. Since neutralizing antibodies are a correlate of protection, we developed a lateral flow assay (LFA) that measures levels of neutralizing antibodies from a drop of bloo...
Autores principales: | Lake, Douglas F., Roeder, Alexa J., Kaleta, Erin, Jasbi, Paniz, Pfeffer, Kirsten, Koelbela, Calvin, Periasamy, Sivakumar, Kuzmina, Natalia, Bukreyev, Alexander, Grys, Thomas E., Wu, Liang, Mills, John R, McAulay, Kathrine, Gonzalez-Moa, Maria, Seit-Nebi, Alim, Svarovsky, Sergei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567411/ https://www.ncbi.nlm.nih.gov/pubmed/34781240 http://dx.doi.org/10.1016/j.jcv.2021.105024 |
Ejemplares similares
-
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
por: Lake, Douglas F., et al.
Publicado: (2022) -
Letter to the editor RE: Fulford et al., 2021 ‘A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2’
por: Lake, Douglas F., et al.
Publicado: (2022) -
Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses
por: Roeder, Alexa J., et al.
Publicado: (2022) -
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG
por: McAulay, Kathrine, et al.
Publicado: (2020) -
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
por: McAulay, Kirsten, et al.
Publicado: (2022)